Clinical trial reportBreast cancer research and treatmentPublished
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)
Regional connection
Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Breast cancer research and treatment
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Breast Neoplasms; Neoplasm Metastasis; Antineoplastic Combined Chemotherapy Protocols; Treatment Outcome; Double-Blind Method; Adult; Aged; Aged, 80 and over; Middle Aged; Female; Bevacizumab
- PubMed ID
- 38967884
- PubMed Central ID
- PMC11297090
- Open access
- Yes, open
- Added to directory
- Source checked